Literature DB >> 7806377

Pseudomonas aeruginosa infection of the cornea and asialo GM1.

Z Zhao1, N Panjwani.   

Abstract

Extensive immunohistochemical and thin-layer chromatogram-immunostain analyses were carried out to establish whether asialo GM1, a glycolipid which contains binding sites for Pseudomonas aeruginosa, is present in corneal epithelium. The data suggest that rabbit corneal epithelium does not contain detectable levels of asialo GM1 even after corneas are scarified and incubated with trypsin, P. aeruginosa, or P. aeruginosa exoproducts to expose potential cryptic sites. Preliminary immunohistochemical analyses indicated that asialo GM1 is also not found in human corneas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7806377      PMCID: PMC173000          DOI: 10.1128/iai.63.1.353-355.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  A histochemical comparison of human corneal stromal glycoconjugates with eight other species. Distinct species-dictated differences in binding sites of Griffonia simplicifolia I.

Authors:  N Panjwani; J Baum
Journal:  Histochemistry       Date:  1988

Review 3.  Animal glycosphingolipids as membrane attachment sites for bacteria.

Authors:  K A Karlsson
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

4.  Beta-adrenergic and serotonergic responsiveness of rabbit corneal epithelial cells in culture.

Authors:  M M Jumblatt; A H Neufeld
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-08       Impact factor: 4.799

5.  Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells.

Authors:  L Saiman; A Prince
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Neutral glycolipids of migrating and nonmigrating rabbit corneal epithelium in organ and cell culture.

Authors:  N Panjwani; G Michalopoulos; J Song; T S Zaidi; G Yogeeswaran; J Baum
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-04       Impact factor: 4.799

7.  Evidence for asialo GM1 as a corneal glycolipid receptor for Pseudomonas aeruginosa adhesion.

Authors:  L D Hazlett; S Masinick; R Barrett; K Rosol
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids.

Authors:  H C Krivan; D D Roberts; V Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Fucose-containing glycolipids are stage- and region-specific antigens in developing embryonic brain of rodents.

Authors:  M Yamamoto; A M Boyer; G A Schwarting
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

10.  Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2).

Authors:  H C Krivan; V Ginsburg; D D Roberts
Journal:  Arch Biochem Biophys       Date:  1988-01       Impact factor: 4.013

View more
  3 in total

1.  Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells.

Authors:  T H Schroeder; T Zaidi; G B Pier
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Inhibition of bacterial adherence to host tissue does not markedly affect disease in the murine model of Pseudomonas aeruginosa corneal infection.

Authors:  T S Zaidi; M J Preston; G B Pier
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

3.  Pathogenesis of corneal infection: binding of Pseudomonas aeruginosa to specific phospholipids.

Authors:  N Panjwani; Z Zhao; M B Raizman; F Jungalwala
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.